Cambridge, Massachusetts Wednesday, August 13, 2025, 15:00 Hrs [IST] ...

Stoke Therapeutics Inc (STOK) reports promising advancements in its Dravet syndrome program and strategic partnerships, ...

Stoke Therapeutics ( ($STOK) ) has released its Q2 earnings. Here is a breakdown of the information Stoke Therapeutics presented to its investors.

The Brennan family will host the 7th Annual Dance for Dravet on September 26th at the Third Degree Glass Factory to raise ...

In the EMPEROR trial, children with a confirmed variant in the SCN1A gene not associated with gain-of-function mutations will receive zorevunersen or a placebo.

The study will assess the efficacy and safety of zorevunersen compared to sham over a 52-week treatment period.

The global Phase III EMPEROR trial (NCT06872125) will evaluate the safety and efficacy of zorevunersen, a novel antisense ...

August 5, 2025Harmony Biosciences Holdings, Inc. misses on earnings expectations. Reported EPS is $0.681 EPS, expectations ...

As I filled out a waiver so he could enter the store’s small play area, I noticed I was the only parent present.” ...

As heatwaves become more intense with climate change, scientists are racing to understand how extreme heat changes the way ...

“He’s just, as you can see, unstoppable,” said Noah’s dad, Andrew Beighley. “For him to still be that happy is something else,” agreed Noah’s mom, Shanice Beighley. Noah is at risk of having a serious ...

With Prince William’s daughter, Princess Charlotte, also in attendance for the final there was speculation that she would be ...